Status:
COMPLETED
Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery
Lead Sponsor:
Foundation for Orthopaedic Research and Education
Conditions:
Post-operative Pain
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.
Eligibility Criteria
Inclusion
- Age 18 years or older
- Requiring shoulder arthroscopic surgery for soft tissue pathology
- Able to complete surveys and follow-up visits
Exclusion
- Younger than 18 years of age
- Shoulder dislocation, fracture, previous surgery, coexisting extremity pathology, pregnancy.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05240755
Start Date
July 1 2022
End Date
August 20 2024
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Orthopaedic Institute
Tampa, Florida, United States, 33736